A new review of GP data conducted by Asthma UK makes for an alarming
reading, showing that over a million people suffering with the lung
condition are not having vital annual check-ups – important in assessing
if asthma medicine is being used in the correct way, to see if lung
function has got better or worse, and to check if patient’s asthma inhalers are the most appropriate ones for them.
The new research conducted by Asthma UK discovered that 31% of asthma
patients had not received an essential annual review to look at the
suitability of their prescribed asthma medicine.
The charity analysed GP statistics from
2012/13 and found that 3,359,612 people in England were scheduled for an
asthma review, however 1,025,539 patients had not attended.
Guidance published by the NHS advises all asthma patients to
attend their yearly checks as well as keep an asthma action plan and
have their inhaler technique looked at. For instance, GPs and asthma
nurses need to see if the patient ‘test’ the device first, if the
patient shakes the inhaler before using, is breathing out normally,
holding the inhaler upright with lips sealed around it, using one
actuation only per inhalation, and if the patient is holding their
breath for 10 seconds (if possible).
Patients who aren’t using their inhaler correctly may find they are
overusing the blue reliever inhaler because they are not sufficiently
ingesting the drug to start with. Others find they may be using their
relievers far more frequently than previously, and more often than not,
these people are not bothering to use the brown preventer inhalers which are massively important in building a long-term improvement.
For example, it can take between 7 to 14 days for the brown preventer
to build up its effect, or sometimes as much as six weeks, and will not
give immediate relief of symptoms like the blue inhaler offers. The
benefits of the brown inhaler build up over time and will decrease the
chance of an asthma attack/symptoms occurring by slowly building
resistance to triggers.
A recently conducted UK-wide National Review of Asthma Deaths found
prescribing mistakes in almost half (47%) of asthma deaths and the
quality of care could have been improved in a staggering 83% of the
deaths.
The National Review also discovered that only 57% of these patients
had received an annual asthma review in the last year of their life.
From the other 43% that did have a review, many of these had not even
included key components.
Dr Samantha Walker, Deputy Chief Executive of Asthma UK, was speaking
on the finding that a quarter of people with asthma in the North of
England had not had a review of their condition.
She said: “The fact that over a quarter of people with asthma in the
North of England are not getting their medicines checked at their annual
review is no doubt contributing to the rising NHS spend on asthma and
putting people’s lives at risk. With the worrying scale of prescribing
errors identified by the National Review of Asthma Deaths, it’s vital
that doctors and nurses do everything they can to follow up with
patients to review their medicines, especially as asthma can vary hugely
over the year. We’re keen to understand where further improvements can
be made to asthma care in the North of England so urge people with
asthma to complete our survey www.asthma.org.uk/compareyourcare to find
out how their care compares to national standards”.
No comments:
Post a Comment